Does PEMIGATINIB Cause Off label use? 114 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 114 reports of Off label use have been filed in association with PEMIGATINIB (PEMAZYRE). This represents 16.1% of all adverse event reports for PEMIGATINIB.
114
Reports of Off label use with PEMIGATINIB
16.1%
of all PEMIGATINIB reports
28
Deaths
19
Hospitalizations
How Dangerous Is Off label use From PEMIGATINIB?
Of the 114 reports, 28 (24.6%) resulted in death, 19 (16.7%) required hospitalization, and 2 (1.8%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEMIGATINIB. However, 114 reports have been filed with the FAERS database.
What Other Side Effects Does PEMIGATINIB Cause?
Disease progression (103)
Death (76)
Fatigue (72)
Alopecia (53)
Hyperphosphataemia (46)
Cholangiocarcinoma (44)
Diarrhoea (42)
Constipation (37)
Drug ineffective (37)
Hospitalisation (35)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which PEMIGATINIB Alternatives Have Lower Off label use Risk?
PEMIGATINIB vs PENICILLAMINE
PEMIGATINIB vs PENICILLIN
PEMIGATINIB vs PENICILLIN G
PEMIGATINIB vs PENICILLIN G BENZATHINE
PEMIGATINIB vs PENICILLIN G PROCAINE